---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-008294"
form_type: "8-K"
ticker: "NXTS"
cik: "0001789192"
company_name: "Nexentis Technologies Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T03:47:48.725411+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# N2OFF signs definitive agreement to acquire MitoCareX Bio in stock-cash deal

## Summary
- N2OFF will pay $700,000 cash to SciSparc for 4,961 shares and issue common stock totaling 40% of fully diluted capital to all sellers.
- Sellers eligible for milestone-based issuance of up to 25% additional common stock and 30% of N2OFF financing proceeds capped at $1.6M over 5 years.
- N2OFF commits initial $1M investment in MitoCareX plus ongoing funding; MitoCareX becomes wholly-owned subsidiary upon closing.
- Transaction subject to N2OFF stockholder approval; board members Amitay Weiss and Liat Sidi also serve on SciSparc board (related party).

## SEC filing metadata
- accession: 0001493152-25-008294
- form_type: 8-K
- ticker: NXTS
- cik: 0001789192
- company_name: Nexentis Technologies Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1789192/000149315225008294/0001493152-25-008294-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1789192/000149315225008294/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-008294
- JSON: https://secwatch.observer/filing/0001493152-25-008294.json
- Plain text: https://secwatch.observer/filing/0001493152-25-008294.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.